» Articles » PMID: 10537961

Prescribing at the Interface Between Primary and Secondary Care in the UK. Towards Joint Formularies?

Overview
Specialty Pharmacology
Date 1999 Oct 28
PMID 10537961
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The current divisions in managing prescribing between primary and secondary care in the UK arise from separate budgetary arrangements. These divisions are neither sensible, organisationally efficient nor cost effective. Transition of patients across the interface of primary and secondary care has always been problematic, hindered by poor communication and coordination. Joint formularies would improve overall care and raise awareness of the need to consider overall costs within a unified National Health Service (NHS). There are, however, few examples of successful working of a joint formulary in the UK. It is likely that harmonisation of drug use in hospitals and in primary care will come about because of contracting and commissioning, and that it will largely be led by primary care, through the developing primary care groups (PCGs). Local decisions around availability and use of drug therapies will increasingly be superseded by the national decisions emanating from the newly formed National Institute for Clinical Effectiveness.

Citing Articles

Biosimilar uptake by British local formularies: a cross sectional study.

Alnahar S, Elliott R, Smith M Int J Clin Pharm. 2017; 39(5):1055-1060.

PMID: 28871421 PMC: 5686267. DOI: 10.1007/s11096-017-0523-6.


Evaluation of angiotensin II receptor blockers for drug formulary using objective scoring analytical tool.

Lim T, Ibrahim M Pharm Pract (Granada). 2013; 10(3):136-42.

PMID: 24155829 PMC: 3780493. DOI: 10.4321/s1886-36552012000300003.


The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study.

Grimmsmann T, Schwabe U, Himmel W Eur J Clin Pharmacol. 2007; 63(8):783-90.

PMID: 17549465 DOI: 10.1007/s00228-007-0325-1.


Insufficient communication about medication use at the interface between hospital and primary care.

Glintborg B, Andersen S, Dalhoff K Qual Saf Health Care. 2007; 16(1):34-9.

PMID: 17301202 PMC: 2464919. DOI: 10.1136/qshc.2006.019828.


[A systematic review of therapy coordination between primary and specialist care].

Fernandez Liz E, Luque Mellado F Aten Primaria. 2007; 39(1):15-21.

PMID: 17286919 PMC: 7713405. DOI: 10.1157/13098274.


References
1.
Evans D . A stakeholder analysis of developments at the primary and secondary care interface. Br J Gen Pract. 1996; 46(412):675-7. PMC: 1239823. View

2.
Purves I, Nestor G, Williams K . Testing of PRODIGY continues. BMJ. 1998; 316(7133):776-7. PMC: 1112736. View

3.
Young M, Colwill S, Spiby J . Transferring the costs of expensive treatments. Guidelines may clarify responsibility for prescribing. BMJ. 1995; 310(6990):1335. PMC: 2549716. DOI: 10.1136/bmj.310.6990.1335. View

4.
Walley T . A UK national prescribing list?. Pharmacoeconomics. 1995; 7(6):471-4. DOI: 10.2165/00019053-199507060-00001. View

5.
Needham A, Brown M, Freeborn S . Introduction and audit of a general practice antibiotic formulary. J R Coll Gen Pract. 1988; 38(309):166-7. PMC: 1711298. View